Imaging endogenous dopamine competition with [11C]raclopride in the human brain
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
This study images dopamine release in response to a neurochemically specific challenge with the psychostimulant drug methylphenidate. Changes in synaptic dopamine induced by methylphenidate were evaluated with positron emission tomography and [11 C]raclopride, a D 2 receptor radioligand that is sensitive to endogenous dopamine. Methylphenidate significantly decreased striatal [11 C]raclopride binding. The decrease was variable and was negatively correlated with age. Mood and anxiety at baseline, were also correlated with methylphenidate‐induced DA changes. This strategy provides a tool to investigate the responsiveness of the dopamine system in the normal and diseased human brain and to investigate the neurochemical correlates of behavior. © 1994 Wiley‐Liss, Inc.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Neurogenetic Adaptive Mechanisms in Alcoholism
Cloninger, C. R. (1987) · Science · doi:10.1126/science.2882604 · Cited by 2,234
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070 · cited 1×
“Dopamine (DA) is a neurotransmitter that plays a major role in movement, motivation, and reward (Koob and Bloom, 1988; Le Moal and Simon, 1991; Ritz et al., 1987; Wise, 1988).”
BackgroundAntipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
Aromatic Amino Acids and Modification of Parkinsonism
Cotzias, G. C., Van Woert, M. H., & Schiffer, L. M. (1967) · New England Journal of Medicine · doi:10.1056/nejm196702162760703 · Cited by 1,494
Logan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., Hitzemann, R., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,479
Self-citationDOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION
HORNYKIEWICZ, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,442
Factors That Predict Individual Vulnerability to Amphetamine Self-Administration
Piazza, P. V., Deminière, J.-M., Le Moal, M., & Simon, H. (1989) · Science · doi:10.1126/science.2781295 · Cited by 1,351
Research works printed but not linked: 9
- Davis K. L., 1991, Dopamine in schizophrenia: a review and reconceptualization. Am. J, Psychiatry, 148, 1474
- Ekman G., 1967, The measurement of subjective reactions, Forsvarsedicine, 33, 27
- Ferris R., 1972, A comparison of the capabilities of isomers of amphetamine, deoxyperadrol and methylphenidate to inhibit the uptake of catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta, J. Pharmacol., 14, 47
- Innis R. B., 1993, SPECT imaging demonstrates loss of striatal dopamine transporters in parkinson's disease, J. Nucl. Med., 34, 31
- Joseph J. A., 1990, The striatum, a microcosm for the examination of age‐related alterations in the CNS: a selected review. Rev. Biolog. Res, Aging, 4, 181
- Kandel D. B., 1989, Cessation of illicit drug use in young adulthood. Arch. Gen, Psychiatry, 46, 109
- Logan J., 1993, The effects of changes in blood flow on the distribution volume of [11C]raclopride binding, J. Nucl. Med., 34, 200
- Raichle M. E., 1983, Brain blood flow measured with intravenous H2 15O, J. Nucl. Med., 24, 790
- Wong D. F., 1992, C‐11 WIN 35,428 imaging of the dopamine transporter site in living human brain, J. Nucl. Med., 33, 964
Cited by
Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
Logan, J., Fowler, J. S., Volkow, N. D., Wang, G.-J., Ding, Y.-S., & Alexoff, D. L. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00008 · Cited by 1,514
Self-citationThe brain on drugs: from reward to addiction
Volkow, N. D., & Morales, M. (2015) · Cell · doi:10.1016/j.cell.2015.07.046 · Cited by 1,306
“PET studies have made it possible to measure drug-induced DA increases in humans (Volkow et al., 1994)—for instance, in studies that compared the effects of drug intoxication between cocaine abusers and controls, where stimulant drugs such asmethylphenidate and amphetamine were used as…”
Self-citationLaruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291
Evidence for striatal dopamine release during a video game
Koepp, M. J., Gunn, R. N., Lawrence, A. D., Cunningham, V. J., Dagher, A., Jones, T., Brooks, D. J., Bench, C. J., & Grasby, P. M. (1998) · Nature · doi:10.1038/30498 · Cited by 1,279
Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex
Volkow, N. D. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.318 · Cited by 1,240
“Using this strategy it has been shown that with aging there is a decrease in striatal DA release in healthy human subjects (Volkow et al., 1994).”
BackgroundSelf-citationCocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction
Volkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Logan, J., Childress, A.-R., Jayne, M., Ma, Y., & Wong, C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1544-06.2006 · Cited by 1,164
“To test this hypothesis, we studied 18 cocaine-addicted subjects with positron emission tomography (PET) and [ 11 C]raclopride, a DA D 2 receptor ligand sensitive to competition with endogenous DA (Volkow et al., 1994).”
BackgroundSelf-citationBreier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications
Volkow, N. D., Fowler, J. S., Wang, G.-J., & Swanson, J. M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001507 · Cited by 1,101
Self-citationExpectation and Dopamine Release: Mechanism of the Placebo Effect in Parkinson's Disease
de la Fuente-Fernández, R., Ruth, T. J., Sossi, V., Schulzer, M., Calne, D. B., & Stoessl, A. J. (2001) · Science · doi:10.1126/science.1060937 · Cited by 991
Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
Laruelle, M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944
“The first comprehensive report of this effect in humans was published by”
BackgroundVolkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916
Self-citationDecreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Hitzemann, R., Chen, A. D., Dewey, S. L., & Pappas, N. (1997) · Nature · doi:10.1038/386830a0 · Cited by 854
Self-citationVolkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gerasimov, M., Maynard, L., Ding, Y.-S., Gatley, S. J., Gifford, A., & Franceschi, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-j0001.2001 · Cited by 770
“petition with DA, a property that can be used to measure druginduced changes in extracellular DA ( Volkow et al., 1994 ).”
BackgroundMethodInfluentialSelf-citationIncreased dopamine transmission in schizophrenia: relationship to illness phases
Laruelle, M., Abi-Dargham, A., Gil, R., Kegeles, L., & Innis, R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00067-0 · Cited by 715
Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria
Drevets, W. C., Gautier, C., Price, J. C., Kupfer, D. J., Kinahan, P. E., Grace, A. A., Price, J. L., & Mathis, C. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01038-6 · Cited by 706
“…DA receptor radioligand displacement during AMPH, cocaine, or methylphenidate administration did not obtain measures specifically from the ventral striatum or compare the strength of such correlations across striatal subregions (Laruelle et al 1995; Schlaepfer et al 1997; Volkow et al 1994b, 1999).”
BackgroundThe dopamine theory of addiction: 40 years of highs and lows
Nutt, D. J., Lingford-Hughes, A., Erritzoe, D., & Stokes, P. R. A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3939 · Cited by 649
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631
“Another fMRI study reported MPH-induced activation in the putamen during a go/no-go task when a response inhibition error occurred but not when a response was successfully inhibited (Costa et al., 2013), suggesting that the effects of MPH are context dependent.”
InfluentialEvidence that ‘food addiction’ is a valid phenotype of obesity
Davis, C., Curtis, C., Levitan, R. D., Carter, J. C., Kaplan, A. S., & Kennedy, J. L. (2011) · Appetite · doi:10.1016/j.appet.2011.08.017 · Cited by 545
“In particular, negative affect and anxiety have been shown to correlate positively with increases in brain dopamine levels and greater subjective feelings of happiness (‘high’) in response to a psychomotor stimulant drug (Volkow et al., 1994).”
BackgroundVolkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Thanos, P. K., Logan, J., Alexoff, D., Ding, Y.-S., Wong, C., Ma, Y., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.06.002 · Cited by 573
Self-citationMartinez, D., Slifstein, M., Broft, A., Mawlawi, O., Hwang, D.-R., Huang, Y., Cooper, T., Kegeles, L., Zarahn, E., Abi-Dargham, A., et al. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000048520.34839.1a · Cited by 569
“For example, the administration of psychostimulants such as amphetamine or methylphenidate is associated with an acute reduction in the binding potential (BP) of the radiotracers [(11)C]raclopride or [(123)I]IBZM (Volkow et al., 1994; Laruelle et al., 1995; Breier et al., 1997).”
BackgroundSelf-citationNeurobiologic processes in drug reward and addiction
Adinoff, B. (2004) · Harvard Review of Psychiatry · doi:10.1080/10673220490910844 · Cited by 546
Volkow, N. D., Fowler, J. S., Logan, J., Alexoff, D., Zhu, W., Telang, F., Wang, G.-J., Jayne, M., Hooker, J. M., Wong, C., et al. (2009) · JAMA · doi:10.1001/jama.2009.351 · Cited by 529
“[(11)C]Raclopride (dopamine D2/D3 radiotracer labeled with carbon 11 that competes for binding with endogenous dopamine(18)) was used to serve as an indicator of changes in extracellular dopamine and [(11)C]cocaine to measure dopamine transporter availability.(18,19) Measures were obtained after a placebo and after an…”
MethodSelf-citationMawlawi, O., Martinez, D., Slifstein, M., Broft, A., Chatterjee, R., Hwang, D.-R., Huang, Y., Simpson, N., Ngo, K., Van Heertum, R., et al. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200109000-00002 · Cited by 525
“However, given the wellestablished sensitivity of [11C]raclopride to competition by endogenous dopamine (Volkow et al., 1994; Carson et al., 1997), the authors also investigated the displaceability and reproducibility of thalamic [11C]raclopride uptake in this data set, to assess the feasibility of…”
BackgroundVolkow, N. (2002) · Neurobiology of Learning and Memory · doi:10.1006/nlme.2002.4099 · Cited by 514
“To test this hypothesis we used PET and [ 11 C]raclopride (radioligand whose binding to D2 receptors is sensitive to competition with endogenous DA (Volkow et al., 1994)) to measure changes in brain DA after different doses of iv MP in healthy controls.”
Self-citationWang, G.-J., Volkow, N. D., Thanos, P. K., & Fowler, J. S. (2004) · Journal of Addictive Diseases · doi:10.1300/j069v23n03_04 · Cited by 502
Self-citationMalison, R. T., Price, L. H., Berman, R., van Dyck, C. H., Pelton, G. H., Carpenter, L., Sanacora, G., Owens, M. J., Nemeroff, C. B., Rajeevan, N., et al. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00272-8 · Cited by 496
Volkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Logan, J., Jayne, M., Ma, Y., Pradhan, K., & Wong, C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3371-07.2007 · Cited by 494
“For the [ 11C]raclopride images, regions of interest (ROIs) were obtained directly from the [ 11C]raclopride images as described previously (Volkow et al., 1994a).”
BackgroundMethodSelf-citationVariables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHD
Volkow, N. D., & Swanson, J. M. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.11.1909 · Cited by 475
Self-citationDopamine as the wind of the psychotic fire: new evidence from brain imaging studies
Laruelle, M., & Abi-Dargham, A. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300405 · Cited by 461
“…methylphenidate (0.5mg/kg) resulted in signi®cant decrease in [123I]IBZM BP. Similar studies have been performed in healthy volunteers with PET and [11C]raclopride, using the constant infusion technique (Breier et al., 1997) or a double single-bolus injection technique (Volkow et al., 1994).”
BackgroundMethodVolkow, N. D., Wang, G., Fowler, J. S., Logan, J., Jayne, M., Franceschi, D., Wong, C., Gatley, S. J., Gifford, A. N., Ding, Y., et al. (2002) · Synapse · doi:10.1002/syn.10075 · Cited by 452
“For this purpose, 10 healthy male subjects were studied with PET and [11C]raclopride, a DA D2 receptor ligand sensitive to competition with endogenous DA (Seeman et al., 1996; Volkow et al., 1994).”
MethodSelf-citationVolkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Wong, C., Hitzemann, R., & Pappas, N. R. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35115-8 · Cited by 422
“Because [11C]raclopride binding in the human brain is highly reproducible (Volkow et al., 1993), differences in binding between placebo and MP predominantly reflect MP-induced changes in synaptic DA, which occupies DA D2 receptors (Volkow et al., 1994; Breier et al., 1997).”
BackgroundSelf-citationRole of dopamine in drug reinforcement and addiction in humans: results from imaging studies
Volkow, N. D., Fowler, J. S., & Wang, G.-J. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200209000-00008 · Cited by 398
“This was done by assessing the changes in extracellular DA that occur after MP administration, using PET and [(11)C]raclopride (Volkow et al., 1994).”
InfluentialSelf-citationVolkow, N. D., Wang, G.-J., Fowler, J. S., & Ding, Y.-S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.006 · Cited by 368
Self-citationSex Differences in Striatal Dopamine Release in Healthy Adults
Munro, C. A., McCaul, M. E., Wong, D. F., Oswald, L. M., Zhou, Y., Brasic, J., Kuwabara, H., Kumar, A., Alexander, M., Ye, W., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.008 · Cited by 350
Laruelle, M. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00054-5 · Cited by 358
Mechanism of action of methylphenidate: Insights from PET imaging studies
Volkow, N. D., Fowler, J. S., Wang, G., Ding, Y., & Gatley, S. J. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s05 · Cited by 353
Self-citationSmoking-Induced Ventral Striatum Dopamine Release
Brody, A. L., Olmstead, R. E., London, E. D., Farahi, J., Meyer, J. H., Grossman, P., Lee, G. S., Huang, J., Hahn, E. L., & Mandelkern, M. A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1211 · Cited by 347
“to cocaine (14), amphetamine (15–17), and methylphenidate (18) administration in humans, as well as to nicotine”
BackgroundVideo Games and Rehabilitation: Using Design Principles to Enhance Engagement in Physical Therapy
Lohse, K., Shirzad, N., Verster, A., Hodges, N., & Van der Loos, H. F. M. (2013) · Journal of Neurologic Physical Therapy · doi:10.1097/npt.0000000000000017 · Cited by 316
Lieberman, J. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00045-6 · Cited by 333
Self-citationVolkow, N. D., Wang, G.-J., Newcorn, J., Telang, F., Solanto, M. V., Fowler, J. S., Logan, J., Ma, Y., Schulz, K., Pradhan, K., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.8.932 · Cited by 331
“Differences in specific binding of [(11)C]raclopride with and without methylphenidate mostly reflect methylphenidateinduced changes in extracellular DA.(14) In parallel we quantified clinical symptoms before the study using the Conners Adult ADHD Rating Scales (CAARS)(15) and “drug liking” after intravenous administra…”
MethodInfluentialSelf-citationSPECT imaging of striatal dopamine release after amphetamine challenge.
Laruelle, M. A., Abi‐Dargham, A., van Dyck, C. H., Rosenblatt, W. H., Zea‐Ponce, Y., Zoghbi, S. S., Baldwin, R. M., Charney, D. S., Hoffer, P. B., & Kung, H. F. (1995) · PubMed · Cited by 331
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Franceschi, D., Maynard, L., Ding, Y., Gatley, S. J., Gifford, A., Zhu, W., et al. (2002) · Synapse · doi:10.1002/syn.10038 · Cited by 321
“PET was used with [11C]cocaine, a DAT ligand (Fowler et al., 1989), to measure the levels of DAT blockade by MP and with [11C]raclopride, a DA D2 receptor radioligand sensitive to competition with DA, to measure MP-induced changes in extracellular DA (Volkow et al., 1994).”
MethodResultInfluentialSelf-citationComputer and Video Game Addiction—A Comparison between Game Users and Non-Game Users
Weinstein, A. M. (2010) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2010.491879 · Cited by 277
“This is comparable to measures of dopamine release produced by amphetamine (49) or methylphenidate (50, 51).”
Oswald, L. M., Wong, D. F., McCaul, M., Zhou, Y., Kuwabara, H., Choi, L., Brasic, J., & Wand, G. S. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300667 · Cited by 314
“This radioligand is a low-affinity antagonist at D2 and D3 receptors that has previously been shown to be sensitive to stimulant-induced changes in DA concentration in the brain (Endres et al, 1997; Volkow et al, 1994).”
Boileau, I., Dagher, A., Leyton, M., Gunn, R. N., Baker, G. B., Diksic, M., & Benkelfat, C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.12.1386 · Cited by 305
Volkow, N. D., Wang, G.-J., Ma, Y., Fowler, J. S., Wong, C., Ding, Y.-S., Hitzemann, R., Swanson, J. M., & Kalivas, P. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0433-05.2005 · Cited by 304
“…two sequential doses of intravenous MP. PET imaging of [ 18 F]deoxyglucose (FDG) was used to measure the effects of MP in brain glucose metabolism (marker of brain function) (Sokoloff et al., 1977), and imaging of [ 11 C]raclopride was used to measure DA transmission (Volkow et al., 1994).”
InfluentialSelf-citationWang, G. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00184-4 · Cited by 285
Self-citationVolkow, N. D., Wang, G.-J., Fowler, J. S., Telang, F., Maynard, L., Logan, J., Gatley, S. J., Pappas, N., Wong, C., Vaska, P., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1173 · Cited by 281
Self-citationBrain DA D2 receptors predict reinforcing effects of stimulants in humans: Replication study
Volkow, N. D., Wang, G., Fowler, J. S., Thanos, P., Logan, J., Gatley, S. J., Gifford, A., Ding, Y., Wong, C., & Pappas, N. (2002) · Synapse · doi:10.1002/syn.10137 · Cited by 275
“© 2002 WILEY-LISS, INC. DA (Volkow et al., 1994), which could fluctuate between experiments, we measured the correlation with drug-liking for two D2 receptor measures performed on separate days.”
BackgroundSelf-citationGambling Disorder and Other Behavioral Addictions: Recognition and Treatment
Yau, Y. H. C., & Potenza, M. N. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000051 · Cited by 267
Deisz, R. A., Billard, J.-M., & Zieglg�nsberger, W. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199701)25:1<62::aid-syn8>3.0.co;2-d · Cited by 112
Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates
Laruelle, M., Iyer, R. N., Al-Tikriti, M. S., Zea-Ponce, Y., Malison, R., Zoghbi, S. S., Baldwin, R. M., Kung, H. F., Charney, D. S., Hoffer, P. B., et al. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199701)25:1<1::aid-syn1>3.0.co;2-h · Cited by 265
“The reduction in [11C]raclopride binding produced by GBR-12909 in baboons or methylphenidate in humans was not increased with increasing doses of the pharmacological agent (Dewey et al., 1993; Volkow et al., 1994).”
Imaging D2 Receptor Occupancy by Endogenous Dopamine in Humans
Laruelle, M. D. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00043-2 · Cited by 266
“…positron emission tomography (PET) and single photon emission computerized tomography (SPECT) radiotracers in baboons (Logan et al. 1991; Innis et al. 1992; Dewey et al. 1993; Kessler et al. 1993; Laruelle et al. 1997) and in humans (Farde et al. 1992; Volkow et al. 1994; Laruelle et al. 1995).”
BackgroundElevated Intrasynaptic Dopamine Release in Tourette’s Syndrome Measured by PET
Singer, H. S., Szymanski, S., Giuliano, J., Yokoi, F., Dogan, A. S., Brasic, J. R., Zhou, Y., Grace, A. A., & Wong, D. F. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1329 · Cited by 259
Sex Differences in the Striatal Dopamine D2 Receptor Binding Characteristics in Vivo
Pohjalainen, T., Rinne, J. O., Någren, K., SyvÄlahti, E., & Hietala, J. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.768 · Cited by 247
Evidence that sleep deprivation downregulates dopamine D2R in ventral striatum in the human brain
Volkow, N. D., Tomasi, D., Wang, G.-J., Telang, F., Fowler, J. S., Logan, J., Benveniste, H., Kim, R., Thanos, P. K., & Ferré, S. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0045-12.2012 · Cited by 254
“Regions of interest (ROIs) were obtained directly from the [ 11C]raclopride images as previously described (Volkow et al., 1994, 1995).”
BackgroundMethodInfluentialSelf-citationPET evaluation of the dopamine system of the human brain.
Volkow, N. D., Fowler, J., Sj, G., Logan, J., Wang, G., Ding, Y., & Dewey, S. L. (1996) · PubMed · Cited by 299
Self-citationBrain dopamine transporter levels in treatment and drug naive adults with ADHD
Volkow, N. D., Wang, G.-J., Newcorn, J., Fowler, J. S., Telang, F., Solanto, M. V., Logan, J., Wong, C., Ma, Y., Swanson, J. M., et al. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.10.014 · Cited by 249
“We manually obtained regions of interest (ROI) in the left and right caudate, putamen and cerebellum (CB) as previously described (Volkow et al., 1994).”
MethodInfluentialSelf-citationDe La Fuente‐Fernández, R., Lu, J., Sossi, V., Jivan, S., Schulzer, M., Holden, J. E., Lee, C. S., Ruth, T. J., Calne, D. B., & Stoessl, A. J. (2001) · Annals of Neurology · doi:10.1002/ana.65 · Cited by 247
Hilker, R., Klein, C., Ghaemi, M., Kis, B., Strotmann, T., Ozelius, L. J., Lenz, O., Vieregge, P., Herholz, K., Heiss, W., et al. (2001) · Annals of Neurology · doi:10.1002/ana.74 · Cited by 243
Volkow, N. D., Wang, G.-J., Tomasi, D., Kollins, S. H., Wigal, T. L., Newcorn, J. H., Telang, F. W., Fowler, J. S., Logan, J., Wong, C. T., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4461-11.2012 · Cited by 237
“Dynamic scans were obtained for a total of 60 min as described previously (Volkow et al., 1994).”
MethodInfluentialSelf-citationBrain dopamine is associated with eating behaviors in humans
Volkow, N. D., Wang, G., Maynard, L., Jayne, M., Fowler, J. S., Zhu, W., Logan, J., Gatley, S. J., Ding, Y., Wong, C., et al. (2003) · International Journal of Eating Disorders · doi:10.1002/eat.10118 · Cited by 235
Self-citationVolkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Alexoff, D., Logan, J., Jayne, M., Wong, C., & Tomasi, D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411228111 · Cited by 230
Self-citationVolkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Logan, J., Childress, A.-R., Jayne, M., Ma, Y., & Wong, C. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.09.059 · Cited by 224
“Positron emission tomography (PET) and [11C]raclopride (DA D2 receptor radioligand sensitive to competition with endogenous DA (Volkow et al., 1994)) were used to measure the DA changes induced by MP for both conditions, which were compared against measures obtained after a placebo presented with a…”
MethodSelf-citationVolkow, N. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00104-9 · Cited by 217
Self-citationConditioned cues and the expression of stimulant sensitization in animals and humans
Vezina, P., & Leyton, M. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.070 · Cited by 213
“…also increased in human striatum (especially ventral subregions) following the acute administration of various abused drugs including amphetamine (Volkow et al., 1994, 1997, 1999, 2001; Laruelle et al., 1995; Breier et al., 1997; Drevets et al., 2001; Leyton et al., 2002; Martinez et al., 2003,…”
BackgroundMartinez, D., Carpenter, K. M., Liu, F., Slifstein, M., Broft, A., Friedman, A. C., Kumar, D., Van Heertum, R., Kleber, H. D., & Nunes, E. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10050748 · Cited by 212
Addiction science: Uncovering neurobiological complexity
Volkow, N. D., & Baler, R. D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.007 · Cited by 193
“In humans, PET studies have shown that several drugs [stimulants (Drevets et al., 2001; Volkow et al., 1999c, 1994), nicotine (Brody et al., 2009), alcohol (Boileau et al., 2003), and cannabis (Bossong et al., 2009)] increase DA in dorsal and ventral striatum (where the NAc is located).”
BackgroundSelf-citationSleep Deprivation Decreases Binding of [11C]Raclopride to Dopamine D2/D3Receptors in the Human Brain
Volkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Logan, J., Wong, C., Ma, J., Pradhan, K., Tomasi, D., Thanos, P. K., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1443-08.2008 · Cited by 192
“…used positron emission tomography (PET) and [ 11C]raclopride, a radiotracer that is sensitive to competition with endogenous DA to measure changes in DA (Volkow et al., 1994), and [ 11C]cocaine to measure DA transporters (DATs) Received April 4, 2008; revised June 24, 2008; accepted July 17, 2008.”
MethodSelf-citationSmith, P. D. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00092-4 · Cited by 201
“123 I-IBZM, 11 C-raclopride), due to the increased competition between dopamine and for binding to the striatal D 2 receptor (Dewey et al. 1991, 1993a; Innis et al. 1992; Volkow et al., 1994).”
BackgroundKinetic Modeling of [11C]Raclopride: Combined PET-Microdialysis Studies
Endres, C. J., Kolachana, B. S., Saunders, R. C., Su, T., Weinberger, D., Breier, A., Eckelman, W. C., & Carson, R. E. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199709000-00002 · Cited by 194
Lejeune, F., & Millan, M. J. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199810)30:2<172::aid-syn7>3.0.co;2-9 · Cited by 99
Self-citationDopamine D2 Receptors in the Insular Cortex and the Personality Trait of Novelty Seeking
Suhara, T., Yasuno, F., Sudo, Y., Yamamoto, M., Inoue, M., Okubo, Y., & Suzuki, K. (2001) · NeuroImage · doi:10.1006/nimg.2001.0761 · Cited by 184
Ventral Striatal Dopamine Release in Response to Smoking a Regular vs a Denicotinized Cigarette
Brody, A. L., Mandelkern, M. A., Olmstead, R. E., Allen-Martinez, Z., Scheibal, D., Abrams, A. L., Costello, M. R., Farahi, J., Saxena, S., Monterosso, J., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.87 · Cited by 183
“Although this radiotracer is commonly used for the evaluation of DA release (Volkow et al, 1994; Carson et al, 1997; Schlaepfer et al, 1997; Ginovart et al, 2002; Brody et al, 2004, 2006; Marenco et al, 2004; Barrett et al, 2004; Scott et al, 2007) and generally demonstrates DA release when…”
MethodMartinez, D. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00216-5 · Cited by 182
“Linkage disequilibrium between attention deficit hyperactivity disorder (ADHD) and the 10-repeat allele has been demonstrated in 4 studies (Cook et al. 1995; Daly et al. 1999; Gill et al. 1997; Waldman et al. 1998).”
Individual variation in resisting temptation: Implications for addiction
Saunders, B. T., & Robinson, T. E. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.008 · Cited by 166
Monte-Silva, K., Liebetanz, D., Grundey, J., Paulus, W., & Nitsche, M. A. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.190181 · Cited by 170
“Increased age reduces dopaminergic signalling, and receptor density (Volkow et al. 1994; Flöel et al. 2008).”
BackgroundAn integrated view of pathophysiological models of schizophrenia
Duncan, G. E., Sheitman, B. B., & Lieberman, J. A. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00002-8 · Cited by 176
Self-citationReuter, M., Schmitz, A., Corr, P., & Hennig, J. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005419 · Cited by 168
“They conclude that the low binding potential of the radioactive ligand [ 11 C]FLB457 resulted from increased endogenous DA due to competitive binding (Dewey et al., 1993; Volkow et al., 1994).”
Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity
Trifilieff, P., & Martinez, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.031 · Cited by 171
“…the specific binding of the radiotracer to the receptor normalized by the nonspecific binding); and 2) the percent decrease in radiotracer binding resulting from increased endogenous dopamine (DBPND), which provides an estimate of pre-synaptic dopamine release (Laruelle, 2000; Volkow et al., 1994).”
Background(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.1.50 · Cited by 171
Self-citationThe dopaminergic basis of human behaviors: A review of molecular imaging studies
Egerton, A., Mehta, M. A., Montgomery, A. J., Lappin, J. M., Howes, O. D., Reeves, S. J., Cunningham, V. J., & Grasby, P. M. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.05.005 · Cited by 159
“…in binding of the D2/3 receptor PET radiotracer [11C]raclopride in response to administration of amphetamine were published in 1992 (Farde et al., 1992) and similar results were subsequently obtained following administration of the DA re-uptake inhibitor methylphenidate (Volkow et al., 1994).”
ResultMartinez, D., Saccone, P. A., Liu, F., Slifstein, M., Orlowska, D., Grassetti, A., Cook, S., Broft, A., Van Heertum, R., & Comer, S. D. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.08.024 · Cited by 161
“In the setting of increased dopamine, fewer D2/3 receptors are available to bind to [11C]raclopride, and the percent decrease in binding provides an estimate of the stimulant-induced increase in extracellular dopamine (3, 5).”
BackgroundMethodPain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction
Jarcho, J. M., Mayer, E. A., Jiang, Z. K., Feier, N. A., & London, E. D. (2012) · Pain · doi:10.1016/j.pain.2012.01.002 · Cited by 158
Caffeine Increases Striatal Dopamine D2/D3 Receptor Availability in the Human Brain
Volkow, N. D., Wang, G.-J., Logan, J., Alexoff, D., Fowler, J. S., Thanos, P. K., Wong, C., Casado, V, Ferre, S., & Tomasi, D. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.46 · Cited by 163
Self-citationLogan, J., Volkow, N. D., Fowler, J. S., Wang, G.-J., Dewey, S. L., MacGregor, R., Schlyer, D., Gatley, S. J., Pappas, N., King, P., et al. (1994) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1994.132 · Cited by 167
Self-citationHilker, R., Voges, J., Ghaemi, M., Lehrke, R., Rudolf, J., Koulousakis, A., Herholz, K., Wienhard, K., Sturm, V., & Heiss, W. (2003) · Movement Disorders · doi:10.1002/mds.10297 · Cited by 157
Ding, Y.-S., Fowler, J. S., Volkow, N. D., Dewey, S. L., Wang, G.-J., Logan, J., Gatley, S. J., & Pappas, N. (1997) · Psychopharmacology · doi:10.1007/s002130050267 · Cited by 157
Self-citationNeuroimaging for drug addiction and related behaviors
Parvaz, M. A., Alia-Klein, N., Woicik, P. A., Volkow, N. D., & Goldstein, R. Z. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.055 · Cited by 151
Self-citationImaging in Parkinson’s Disease: The Role of Monoamines in Behavior
Brooks, D. J., & Piccini, P. P. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.12.017 · Cited by 158
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.9.1209 · Cited by 148
“(15) demonstrated changes in dopamine concentration induced by methylphenidate.”
BackgroundEndogenous dopamine release after pharmacological challenges in Parkinson's disease
Piccini, P., Pavese, N., & Brooks, D. J. (2003) · Annals of Neurology · doi:10.1002/ana.10526 · Cited by 147
PET and drug research and development.
Fowler, J. S., Volkow, N. D., Wang, G., Ding, Y., & Dewey, S. L. (1999) · PubMed · Cited by 143
Self-citationPET studies of the effects of aerobic exercise on human striatal dopamine release.
Wang, G., Volkow, N. D., Fowler, J. S., Franceschi, D., Logan, J., Pappas, N. R., Wong, C., & Netusil, N. (2000) · PubMed · Cited by 168
Self-citationAgeing and the nigrostriatal dopaminergic system
Reeves, S., Bench, C., & Howard, R. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.606 · Cited by 135
“Change in tracer binding following administration of a psychostimulant drug reflects the relative change in synaptic DA levels and hence the responsiveness of the dopaminergic system to pharmacological manipulation (Dewey et al., 1992, 1993; Innis et al., 1992; Volkow et al., 1994b; Laruelle et al., 1995, 1997; Kegele…”
BackgroundInfluentialStimulant-induced dopamine increases are markedly blunted in active cocaine abusers
Volkow, N. D., Tomasi, D., Wang, G.-J., Logan, J., Alexoff, D. L., Jayne, M., Fowler, J. S., Wong, C., Yin, P., & Du, C. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.58 · Cited by 134
Self-citationAmphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans
Riccardi, P., Li, R., Ansari, M. S., Zald, D., Park, S., Dawant, B., Anderson, S., Doop, M., Woodward, N., Schoenberg, E., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300916 · Cited by 134
“Several brain imaging studies have investigated D-amphetamine (D-AMPH)-induced dopamine (DA) release in the striatum (Laruelle et al, 1995; Kegeles et al, 1999; Drevets et al, 2001; Singer et al, 2002; Piccini et al, 2003; Martinez et al, 2003; Volkow et al, 1994, 2004).”
Background21st century neurobehavioral theories of decision making in addiction: Review and evaluation
Bickel, W. K., Mellis, A. M., Snider, S. E., Athamneh, L. N., Stein, J. S., & Pope, D. A. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.09.009 · Cited by 134
“In support of this theory, Positron Emission Tomography (PET) studies in humans have illustrated that stimulants (Drevets et al., 2001; Volkow et al., 1994, 1999), nicotine (Brody et al., 2009), alcohol (Boileau et al., 2003), and marijuana (Bossong et al., 2009) stimulate DA release in the dorsal…”
BackgroundSchiffer, W. K., Volkow, N. D., Fowler, J. S., Alexoff, D. L., Logan, J., & Dewey, S. L. (2006) · Synapse · doi:10.1002/syn.20235 · Cited by 134
“We previously established the usefulness of PET for indirectly measuring changes in synaptic neurotransmitter concentrations (Dewey et al., 1988; Dewey et al., 1990; Dewey et al., 1993; Schloesser et al., 1996; Volkow et al., 1994).”
Self-citationThe Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
Chye, Y., Christensen, E., Solowij, N., & Yücel, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00063 · Cited by 126
“The acute reinforcing effect of addictive substances is thought to be due to their direct or indirect activation of DA neurons along this pathway (16).”
Background
Metadata
- Authors
- Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Schlyer, D., Hitzemann, R., Lieberman, J., Angrist, B., Pappas, N., MacGregor, R., Burr, G., Cooper, T., & Wolf, A. P.
- Affiliations
- State University of New York (US)
- Brookhaven National Laboratory (US)
- Zucker Hillside Hospital (US)
- New York University (US)
- Northport VA Medical Center (US)
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 1994-04
- Volume
- 16
- Issue
- 4
- Pages
- 255-262
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W2006715508
- Cited by
- 379
- References
- 68
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 10 · 2020: 5 · 2019: 8 · 2018: 2 · 2017: 9 · 2016: 6 · 2015: 13 · 2014: 16 · 2013: 12 · 2012: 12
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Synapse (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Energy
- National Institutes of Health (5p01ns015638-15)
- National Institute on Drug Abuse (NIDA 5RO1-DA06891, R01DA006891)
- National Institute of Neurological Disorders and Stroke (NINDS NS15638)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- endogenous dopamine, dopamine release, [11C]raclopride, dopamine D2 receptor, striatal dopamine, psychostimulants, age-related changes, mood, anxiety
- MeSH terms
- Adult, Affect, Anxiety, Basal Ganglia, Binding, Competitive, Brain, Brain Chemistry, Cerebrovascular Circulation, Dopamine, Humans, Male, Methylphenidate, Middle Aged, Salicylamides, Synapses, Tomography, Emission-Computed, Neostriatum, Raclopride, Dopamine D2 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.